Managing T-DXd Adverse Events in the Real World
With the recent expansion of its indications in breast cancer, the use of trastuzumab deruxtecan (T-DXd; Enhertu) has increased. “A lot of us use it more frequently now than in the past,” explained Sid Yadav, MD, breast cancer and gynecologist specialist at Mayo Clinic in Rochester, Minnesota. However, he added that dealing with his adverse …
